Tag: cse:lxx
August 27, 2019
Lexaria Bioscience Announces DehydraTECH Patent for Pharmaceutical Applications of Cannabinoids to Treat Certain Disease Conditions
Lexaria Bioscience Corp. (OTCQX:LXRP, CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 21, 2019
Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil
Lexaria Bioscience Corp. (OTC:LXRP, CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to announce... August 15, 2019
Lexaria Bioscience Announces it has Received Four New Patents
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 14, 2019
Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 13, 2019
Lexaria Bioscience Receives Cannabis R&D License from Health Canada
Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce... August 8, 2019
Lexaria Bioscience Completes Initial Project with Canada’s National Research Council
Lexaria Bioscience Corp. (CSE:LXX, OTCQX:LXRP), (the “Company” or “Lexaria”) an innovator in drug delivery platforms, announces the successful completion of...
August 5, 2019